Abstract
This paper argues that the high number of adverse drugs reactions (ADR) in elderly patients results mostly from their increased use of drugs. This is due to their multiple pathology and symptomatology. Altered drug kinetics and dynamics with ageing are relatively minor causes of ADR’s. Thus a major reduction in ADR’s in this age group would only follow a reduction in prescription rate and the length of treatment. Nevertheless, doctors should still critically review dosage and rely on clinical observation of effect as the maxim for using larger doses.
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call